Vir tus He alth (ASX. VRT ) Sue Channon CE O and Gle nn Powe r - - PowerPoint PPT Presentation
Vir tus He alth (ASX. VRT ) Sue Channon CE O and Gle nn Powe r - - PowerPoint PPT Presentation
Vir tus He alth (ASX. VRT ) Sue Channon CE O and Gle nn Powe r s CF O 2017 Mor gan Stanle y Austr alian E me r ging Companie s Confe r e nc e 15 th June , 2017 DISCL AIME R 2 T he ma te ria l in this pre se nta tio n ha s b e e
2
T he ma te ria l in this pre se nta tio n ha s b e e n pre pa re d b y Virtus He a lth L imite d ABN 80 129 643 492 (“Virtus He a lth”) a nd is g e ne ra l b a c kg ro und info rma tio n a b o ut Virtus He a lth’ s a c tivitie s c urre nt a t the da te o f this pre se nta tio n. T he info rma tio n is g ive n in summa ry fo rm a nd inc lude s fina nc ia l a nd o the r info rma tio n a nd do e s no t purpo rt to b e c o mple te . Info rma tio n in this pre se nta tio n, inc luding fo re c a st fina nc ia l info rma tio n sho uld no t b e c o nside re d a s a dvic e o r a re c o mme nda tio n to inve sto rs o r po te ntia l inve sto rs a nd do e s no t ta ke into a c c o unt inve stme nt o b je c tive s, fina nc ia l situa tio n o r ne e ds o f a ny pa rtic ula r inve sto r. T he se sho uld b e c o nside re d, with o r witho ut pro fe ssio na l a dvic e whe n de c iding if a n inve stme nt is a ppro pria te . Pe rso ns ne e ding a dvic e sho uld c o nsult the ir sto c kb ro ke r, so lic ito r, a c c o unta nt o r o the r inde pe nde nt fina nc ia l a dviso r. T he re le a se , pub lic a tio n o r distrib utio n o f this pre se nta tio n in c e rta in jurisdic tio ns ma y b e re stric te d b y la w a nd the re fo re pe rso ns in suc h jurisdic tio ns into whic h this pre se nta tio n is re le a se d, pub lishe d o r distrib ute d sho uld info rm the mse lve s a b o ut a nd o b se rve suc h re stric tio ns. T his pre se nta tio n do e s no t c o nstitute , o r fo rm pa rt o f, a n o ffe r to se ll o r the so lic ita tio n o f a n o ffe r to sub sc rib e fo r o r b uy a ny se c uritie s, no r the so lic ita tio n o f a ny vo te o r a ppro va l in a ny jurisdic tio n, no r sha ll the re b e a ny sa le , issue o r tra nsfe r o f the se c uritie s re fe rre d to in this pre se nta tio n in a ny jurisdic tio n in c o ntra ve ntio n o f a pplic a b le la w. Ce rta in sta te me nts ma de in this pre se nta tio n a re fo rwa rd-lo o king sta te me nts. T he se fo rwa rd- lo o king sta te me nts a re no t histo ric a l fa c ts b ut ra the r a re b a se d o n Virtus He a lth L imite d’ s c urre nt e xpe c ta tio ns, e stima te s a nd pro je c tio ns a b o ut the industry in whic h Virtus He a lth o pe ra te s, a nd b e lie fs a nd a ssumptio ns. Wo rds suc h a s “a ntic ipa te s”, “e xpe c ts”, “inte nds,”, “pla ns”, “b e lie ve s”, “se e ks”, “e stima te s”, a nd simila r e xpre ssio ns a re inte nde d to ide ntify fo rwa rd-lo o king sta te me nts. T he se sta te me nts a re no t g ua ra nte e s o f future pe rfo rma nc e a nd a re sub je c t to kno wn a nd unkno wn risks, unc e rta intie s a nd o the r fa c to rs, so me o f whic h a re b e yo nd the c o ntro l o f Virtus He a lth, a re diffic ult to pre dic t a nd c o uld c a use a c tua l re sults to diffe r ma te ria lly fro m tho se e xpre sse d o r fo re c a ste d in the fo rwa rd-lo o king sta te me nts. Virtus He a lth c a utio ns inve sto rs a nd po te ntia l inve sto rs no t to pla c e undue re lia nc e o n the se fo rwa rd-lo o king sta te me nts, whic h re fle c t the vie w o f Virtus He a lth o nly a s o f the da te o f this pre se nta tio n. T he fo rwa rd-lo o king sta te me nts ma de in this pre se nta tio n re la te o nly to e ve nts a s o f the da te o n whic h the sta te me nts a re ma de . Virtus He a lth will no t unde rta ke a ny o b lig a tio n to re le a se pub lic ly a ny re visio ns o r upda te s to the se fo rwa rd-lo o king sta te me nts to re fle c t e ve nts, c irc umsta nc e s o r una ntic ipa te d e ve nts o c c urring a fte r the da te o f this pre se nta tio n e xc e pt a s re q uire d b y la w o r b y a ny a ppro pria te re g ula to ry a utho rity. A numb e r o f fig ure s, a mo unts, pe rc e nta g e s, e stima te s, c a lc ula tio ns o f va lue a nd fra c tio ns in this pre se nta tio n a re sub je c t to the e ffe c t o f ro unding . Ac c o rding ly, the a c tua l c a lc ula tio n o f the se fig ure s ma y diffe r fro m the fig ure s se t o ut in this pre se nta tio n. In a dditio n, a numb e r o f fig ure s ha ve b e e n c a lc ula te d o n the b a sis o f a ssume d e xc ha ng e ra te s, a s se t o ut in this pre se nta tio n. T
- the ma ximum e xte nt pe rmitte d b y la w, ne ithe r Virtus He a lth no r its re la te d b o die s c o rpo ra te , dire c to rs, o ffic e rs, e mplo ye e s, a g e nts,
c o ntra c to rs, a dvise rs no r a ny o the r pe rso n, a c c e pts, a nd e a c h e xpre ssly disc la ims, a ny lia b ility, inc luding witho ut limita tio n a ny lia b ility a rising fro m fa ult o r ne g lig e nc e , fo r a ny e rro rs o r missta te me nts in, o r o missio ns fro m, this pre se nta tio n o r a ny dire c t, indire c t o r c o nse q ue ntia l lo ss a rising fro m the use o f this pre se nta tio n o r its c o nte nts o r o the rwise a rising in c o nne c tio n with it.
DISCL AIME R
3
One c hild in e ve ry Austra lia n c la ssro o m…
4
CONT E NT S
VIRT US HE AL T H Ove r vie w 5 E volution & Ne twor k of Ca r e 6 Our Pa tie nts & Se r vic e s 8 L e a ding Minds, L e a ding Sc ie nc e 11 F a c tor s Dr iving Gr
- wth
13 Ne a r T e r m Pr ior itie s 16 Innova tion – Adva nc e d T e c hnolog y 17 Str a te g ic Pla n 20
5
Mar ke t le ade r and lar ge st pr
- vide r
- f fe r
tility se r vic e s in Austr alia and Ir e land with a gr
- wing pr
e se nc e in Singapo r e and De nmar k
One of the la rg e st fe rtility pra c tic e s g loba lly
- F
irst pub lic a lly liste d fe rtility b usine ss
- Cha lle ng ing H1F
Y17 prima rily due to do me stic c o nditio ns driving de c line in re ve nue & e a rning s
- Gro up E
BIIT DA do wn 12.3% to $31.7m (Austra lia n se g me nt do wn 13.1%; Inte rna tio na l se g me nt up 11.7%
- n pc p
Re puta tion for c linic a l a nd sc ie ntific e xc e lle nc e
- 123 fe rtility spe c ia lists a nd o ve r 1200 pro fe ssio na l sta ff
- Inve stme nt in c linic a l a nd sc ie ntific re se a rc h a nd ne w te c hno lo g ie s de live rs impro ve d pa tie nt
- utc o me s a nd g ro wth
- E
a rly a do pte r o f ne w te c hno lo g ie s driving g ro wth
Distinc tive , dive rsifie d a nd ve rtic a lly inte g ra te d mode l with multiple sourc e s of re ve nue
- F
e rtility, Da y Ho spita ls a nd Spe c ia lise d Dia g no stic s
* T
- ta l tre a tme nts inc lude fre sh c yc le s, fro ze n e mb ryo tra nsfe rs a nd IUI
s
VIRT US HE AL T H - WORL D L E ADE R IN F E RT IL IT Y CARE
6
E VOL UT ION OF VIRT US HE AL T H
7
VIRT US HE AL T H NE T WORK OF CARE
ASSIST E D RE PRODUCT IVE SE RVICE S SPE CIAL ISE D DIAGNOST ICS DAY HOSPIT AL S
Austra lia 41 Ire la nd 3 Sing a po re 1 De nma rk 1
F E RT IL IT Y CL INICS
46
H
E mb ryo lo g y 29 And ro lo g y 27 E nd o c rino lo g y 4 PGD 2
L ABORAT ORIE S
62
IVF a nd no n-IVF pro c e d ure s
DAY HOSPIT AL S
6
H
F E RT IL IT Y SPE CIAL IST S
1042 123 227
NUR SE S, COUNSE L L OR S, PAT IE NT SUPPOR T (inc l DIAGNOST ICS)
SCIE NT IST S
8
WHO COME S T O ASK F OR OUR HE L P?
40% o f the patie nts that se e fe r tility spe c ialists have no n IVF tr e atme nt
9
VIRT US T RE AT ME NT ANAL YSIS
6,995 7,346 7,617 7,663 8,510 8,070 785 1,272 1,340
HF Y12 HF Y13 HF Y14 HF Y15 HF Y16 HF Y17
Austra lia n Cyc le s I nte rna tio na l Cyc le s
8,448 9,782 9,410
53% 32% 15%
T r e atme nt Mix
Cyc le F ro ze n AI / OI
Vir tus Cyc le s
10
DIVE RSIF IE D RE VE NUE MIX
11
- I
ndustry le a de r in fe rtility a nd sc ie ntific pra c tic e fo r o ve r 30 ye a rs
- Re c o g nise d b ra nds re g a rde d fo r q ua lity a nd se rvic e
- T
ra c k re c o rd o f a ttra c ting a nd re ta ining hig h q ua lity do c to rs, sc ie ntists & spe c ia list sta ff - inc re a sing numb e r
- f pa tie nts
- T
e c hno lo g y o f a dva nc e d sc ie nc e s, spe c ia lise d dia g no stic s a nd inno va tio n de live rs impro ve d pa tie nt
- utc o me s & re ve nue g ro wth
- E
xpe rie nc e d c linic a l a nd ma na g e me nt te a m with a b ility to drive pra c tic e g ro wth a nd a dd va lue
L E ADING MINDS, L E ADING SCIE NCE
F
- c us o n c linic al and sc ie ntific -le d inno vatio n and patie nt
- utc o me s dr
ive s lo ng te r m gr
- wth
12
DOCT ORS OF VIRT US HE AL T H
One o f the mo st suc c e ssful me dic al c o llabo r atio ns inte r natio nally
13
F ACT ORS DRIVING GROWT H
De mog ra phic & Soc ia l T re nds
- I
nfe rtility is a me dic a l c o nditio n a ffe c ting 1 in 6 c o uple s o f re pro duc tive a g e g lo b a lly
- Gro wing fe ma le po pula tio n, rising ma te rna l a g e a nd g lo b a l
fe rtility ra te s in de c line
- Rising inc ide nc e o f c o nditio ns impa c ting fe rtility e .g . o b e sity
a nd c hla mydia
- Gre a te r c o mmunity a wa re ne ss a nd a c c e pta nc e o f I
VF
- I
nc re a sing numb e r o f sa me se x & sing le wo me n sta rting fa milie s using o ur do no r se rvic e s
- Yo ung a dults inc re a sing ly living with pa re nts – we me e t
so ulma te s in o ur la te 20s/ e a rly 30s a nd se e k re la tio nship a nd fina nc ia l se c urity b e fo re sta rting a fa mily
14
Austra lia
Gove r nme nt r e vie w of Me dic ar e Be ne fits Sc he dule ongoing Change s to Safe ty Ne t r e move d in F e de r al Budge t
I re la nd
Gove r nme nt c onside r ing funding for fe r tility se r vic e s – c ur r e ntly pr ivate ly funde d Pr
- pose d move to
ide ntifie d donor s
Sing a po re
Alignme nt with Austr alia’s RT AC Conse r vative e nvir
- nme nt gr
- wing
inte r e st in PGD/ S ac c e ss in Singapor e
De nma rk
Gove r nme nt r e duc ing public funding for fe r tility se r vic e s – c ur r e ntly pr ivate ly funde d F avor able c hange s to donation le gislation
RE GUL AT ORY E NVIRONME NT
15
- H1F
Y17 g e ne ra l Austra lia n ma rke t a c tivity in e a ste rn se a b o a rd sta te s whe re Virtus o pe ra te s do wn 6.0% c o mpa re d to pc p
- Virtus c yc le a c tivity in H1F
Y17 do wn 7.2% to 8,070 c yc le s o n a like fo r like b a sis
- Re c e nt ma rke t tre nds
- NSW ma rke t do wn 5.4%
- VI
C ma rke t up 4.2%
- QL
D ma rke t up 2%
AUST RAL IAN OPE RAT IONS - F E RT IL IT Y
Vir tus is the mar ke t le ade r in Austr alia
16
NE AR T E RM PRIORIT IE S
Inte r national
- Ac tive ly pursue furthe r o ppo rtunitie s in E
uro pe
- L
e ve ra g e pre se nc e in De nma rk fo r Sc a ndina via n o ppo rtunitie s
Austr alian F e r tility Busine ss
Vic tor ia
- Ma na g e me nt a nd struc tura l c ha ng e s
- Stre ng the ne d sc ie ntific le a de rship - a ppo intme nt o f Pro f Da vid Ga rdne r inte rna tio na lly re no wne d
I VF pio ne e r to e nha nc e sc ie ntific e xc e lle nc e
T F C (Se r vic e Mode ls)
- Re vie w o f c linic a l a nd se rvic e de live ry mo de ls
- Pric ing & pa c ka g ing de ve lo pme nt
Ope r ating E xpe nse s
- T
a rg e te d c o st ma na g e me nt (Vic to ria n Ope ra tio n re struc ture & c e ntra lise d Ma rke ting re struc ture )
Diagnostic s & Day Hospitals
- Ma ximise ve rtic a l inte g ra tio n a nd pa tie nt o utc o me s with a dva nc e d sc ie nc e
- Gro w g e ne ra l fe rtility re la te d pa tho lo g y
- I
nc re a se b usine ss de ve lo pme nt to ta rg e t no n-I VF pro c e dura l g ro wth
Vir tus is we ll plac e d to manage industr y c halle nge s and var iability:
- E
volution of c linic a l pra c tic e & se rvic e de live ry
- Most sig nific a nt drive r is our c ontinue d a dva nc e me nts in te c hnolog y
17
ADVANCE D T E CHNOL OGY
Studying the c hr
- mosomal
str uc tur e of the e ggs spe r m Using time lapse imaging to study e mbr yo gr
- wth
Se le c ting the he althie st spe r m
18
GE NE T IC SCRE E NING OF E MBRYOS
19
INNOVAT ION – DIGIT AL T RANSF ORMAT ION
- Ro ll o ut o f Pa tie nt ma na g e me nt syste m a c ro ss Virtus He a lth
- I
nte g ra tio n with F e rtility Spe c ia list priva te pra c tic e so ftwa re fo r do c to r, pa tie nt a nd e ntire pa tie nt c a re te a m e ffic ie nc y
- Dia g no stic s L
I MS
- Pa tie nt App
Cultur e o f sc ie ntific inno vatio n e xte nds to digital tr ansfo r matio n e mbr ac e me nt suppo r ting patie nt c ar e and dr iving e ffic ie nc y
20
Pur po se : T
- he lp wo me n and me n ac hie ve the ir
aspir atio ns to c r e ate a family
VIRT US HE AL T H ST RAT E GY
Ambition
T
- be a le ading global pr
- vide r
- f ARS base d on;
- Clinic a l & sc ie ntific
e ffe c tive ne ss
- Bre a d th o f c a pa b ility a c ro ss
ARS va lue c ha in
- Ma rke t le a d e rship in c ho se n
g e o g ra phie s & ma rke t se g me nts
- Our pa tie nts b e ing a t the
c e ntre o f e ve rything we d o
Gr
- wth Str
ate gy
ARS
(Do me stic & Inte rna tio na l) Ma rke t pe ne tra tio n b y a c q uisitio n, g re e nfie ld &
- rg a nic g ro wth
Re se a rc h d rive n se rvic e d e ve lo pme nt
Day Hospitals
(Do me stic ) Optimise utilisa tio n & e ffic ie nc y Oppo rtunistic d o me stic a c q uisitio n
Diagnostic s
(Do me stic ) L e ve ra g e fe rtility, g e ne tic s & g e ne ra l pa tho lo g y te sting a c ro ss the b usine ss Othe r d ive rsific a tio n
- ppo rtunitie s
L e ading minds, le ading sc ie nc e
21
ARS is a lo ng-te r m gr
- wth mar
ke t
- Sig nific a nt ope r
a tiona l c ha ng e s to a ddr e ss dome stic situa tion
- Inte r
na tiona l Ope r a tions pe r for ming str
- ng ly a nd dive r
sific a tion str a te g ie s on tr a c k
- De mog r
a phic dr ive r s for ARS g r
- wth r
e ma in fa vour a ble g loba lly